
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) will release earnings results for the first quarter before the opening bell on Thursday, Sept. 11.
Analysts expect the Cambridge, Massachusetts-based company to report a quarterly loss at 96 cents per share, versus a year-ago loss of 87 cents per share. KalVista Pharmaceuticals projects to report quarterly revenue of $2.09 million, according to data from Benzinga Pro.